370 related articles for article (PubMed ID: 26364886)
21. Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study.
Brændengen M; Hansson K; Radu C; Siegbahn A; Jacobsson H; Glimelius B
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e439-45. PubMed ID: 21641122
[TBL] [Abstract][Full Text] [Related]
22. Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy.
Leclerc M; Lartigau E; Lacornerie T; Daisne JF; Kramar A; Grégoire V
Radiother Oncol; 2015 Jul; 116(1):87-93. PubMed ID: 26088157
[TBL] [Abstract][Full Text] [Related]
23. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
[TBL] [Abstract][Full Text] [Related]
24. Automated functional image-guided radiation treatment planning for rectal cancer.
Ciernik IF; Huser M; Burger C; Davis JB; Szekely G
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):893-900. PubMed ID: 15936575
[TBL] [Abstract][Full Text] [Related]
25. FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer.
Bassi MC; Turri L; Sacchetti G; Loi G; Cannillo B; La Mattina P; Brambilla M; Inglese E; Krengli M
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1423-6. PubMed ID: 17931795
[TBL] [Abstract][Full Text] [Related]
26. Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.
Han D; Yu J; Yu Y; Zhang G; Zhong X; Lu J; Yin Y; Fu Z; Mu D; Zhang B; He W; Huo Z; Liu X; Kong L; Zhao S; Sun X
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1235-41. PubMed ID: 19910143
[TBL] [Abstract][Full Text] [Related]
27. A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer.
Muijs CT; Beukema JC; Pruim J; Mul VE; Groen H; Plukker JT; Langendijk JA
Radiother Oncol; 2010 Nov; 97(2):165-71. PubMed ID: 20541273
[TBL] [Abstract][Full Text] [Related]
28. Is image registration of fluorodeoxyglucose-positron emission tomography/computed tomography for head-and-neck cancer treatment planning necessary?
Fried D; Lawrence M; Khandani AH; Rosenman J; Cullip T; Chera BS
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):748-54. PubMed ID: 22414285
[TBL] [Abstract][Full Text] [Related]
29. Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer.
Guido A; Fuccio L; Rombi B; Castellucci P; Cecconi A; Bunkheila F; Fuccio C; Spezi E; Angelini AL; Barbieri E
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):759-63. PubMed ID: 18834671
[TBL] [Abstract][Full Text] [Related]
30. 18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer.
Wang H; Vees H; Miralbell R; Wissmeyer M; Steiner C; Ratib O; Senthamizhchelvan S; Zaidi H
Radiother Oncol; 2009 Nov; 93(2):220-5. PubMed ID: 19767115
[TBL] [Abstract][Full Text] [Related]
31. A gel tumour phantom for assessment of the accuracy of manual and automatic delineation of gross tumour volume from FDG-PET/CT.
Skretting A; Evensen JF; Løndalen AM; Bogsrud TV; Glomset OK; Eilertsen K
Acta Oncol; 2013 Apr; 52(3):636-44. PubMed ID: 23075421
[TBL] [Abstract][Full Text] [Related]
32. Gradient-based delineation of the primary GTV on FDG-PET in non-small cell lung cancer: a comparison with threshold-based approaches, CT and surgical specimens.
Wanet M; Lee JA; Weynand B; De Bast M; Poncelet A; Lacroix V; Coche E; Grégoire V; Geets X
Radiother Oncol; 2011 Jan; 98(1):117-25. PubMed ID: 21074882
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Time-Phase Effect on 18F-FDG PET/CT Delineation Methods for Treatment Planning of Nasopharyngeal Carcinoma.
Chen YZ; Li WF; Wang JY; Wang JM; Ou RY; Zheng XW; Xu YS; Zhao L
Clin Nucl Med; 2016 May; 41(5):354-61. PubMed ID: 26859212
[TBL] [Abstract][Full Text] [Related]
34. Conventional 3D staging PET/CT in CT simulation for lung cancer: impact of rigid and deformable target volume alignments for radiotherapy treatment planning.
Hanna GG; Van Sörnsen De Koste JR; Carson KJ; O'Sullivan JM; Hounsell AR; Senan S
Br J Radiol; 2011 Oct; 84(1006):919-29. PubMed ID: 21224293
[TBL] [Abstract][Full Text] [Related]
35. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
36. The role of
Najem E; Marin T; Zhuo Y; Lahoud RM; Tian F; Beddok A; Rozenblum L; Xing F; Moteabbed M; Lim R; Liu X; Woo J; Lostetter SJ; Lamane A; Chen YE; Ma C; El Fakhri G
Radiother Oncol; 2024 May; 194():110186. PubMed ID: 38412906
[TBL] [Abstract][Full Text] [Related]
37. Tumor volume delineation in head and neck cancer with 18-fluor-fluorodeoxiglucose positron emission tomography: adaptive thresholding method applied to primary tumors and metastatic lymph nodes.
Perez-Romasanta LA; Bellon-Guardia M; Torres-Donaire J; Lozano-Martin E; Sanz-Martin M; Velasco-Jimenez J
Clin Transl Oncol; 2013 Apr; 15(4):283-93. PubMed ID: 22865325
[TBL] [Abstract][Full Text] [Related]
38. Does enhanced CT influence the biological GTV measurement on FDG-PET images?
Vera P; Modzelewski R; Hapdey S; Gouel P; Tilly H; Jardin F; Ruan S; Gardin I
Radiother Oncol; 2013 Jul; 108(1):86-90. PubMed ID: 23618503
[TBL] [Abstract][Full Text] [Related]
39. Evaluating diffusion-weighted magnetic resonance imaging for target volume delineation in head and neck radiotherapy.
Cardoso M; Min M; Jameson M; Tang S; Rumley C; Fowler A; Estall V; Pogson E; Holloway L; Forstner D
J Med Imaging Radiat Oncol; 2019 Jun; 63(3):399-407. PubMed ID: 30816646
[TBL] [Abstract][Full Text] [Related]
40. Consequences of additional use of contrast-enhanced (18)F-FDG PET/CT in target volume delineation and dose distribution for pancreatic cancer.
Li XX; Liu NB; Zhu L; Yuan XK; Yang CW; Ren P; Gong LL; Zhao LJ; Xu WG; Wang P
Br J Radiol; 2015 Jul; 88(1051):20140590. PubMed ID: 25939819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
